Cefazolin sodium and Avapro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin sodium (cefazolin sodium) and Avapro (irbesartan). Common drug interactions include anaemia among females and cerebral infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin sodium and Avapro. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin sodium?

Cefazolin sodium has active ingredients of cefazolin sodium. eHealthMe is studying from 3,649 Cefazolin sodium users. Check the latest studies of Cefazolin sodium.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.



On Jul, 12, 2026

16 people who take Cefazolin sodium and Avapro together, and have interactions are studied.

Cefazolin sodium and Avapro drug interactions.

What are the common drug interactions of Cefazolin Sodium and Avapro, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Drug hypersensitivity
  3. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  4. Renal impairment (severely reduced kidney function)
  5. Alopecia (absence of hair from areas of the body)
  6. Arthralgia (joint pain)
  7. Back pain
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cellulitis (infection under the skin)
  10. Drug ineffective

male:

  1. Cerebral infarction (less blood supply to brain resulting tissue damage)
  2. Rash
  3. Type 2 diabetes mellitus
  4. Urethral stenosis (narrowing of the urethra, may cause decreased urine output)
  5. Weight increased
  6. Gamma-glutamyltransferase increased
  7. International normalised ratio increased
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Renal failure acute (rapid kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

What are the common drug interactions of Cefazolin Sodium and Avapro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Generalised oedema (swelling all over the body)
  2. Haemorrhage subcutaneous (bleeding from skin)

50-59:

  1. Calculus urethral (stone in urethra)
  2. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  3. Obstruction gastric (obstruction in stomach)
  4. Pain
  5. Pancreatitis (inflammation of pancreas)
  6. Pancreatitis acute (sudden inflammation of pancreas)
  7. Type 2 diabetes mellitus
  8. Urethral stenosis (narrowing of the urethra, may cause decreased urine output)
  9. Weight increased
  10. Gamma-glutamyltransferase increased

60+:

  1. Renal impairment (severely reduced kidney function)
  2. Anaemia (lack of blood)
  3. Dehydration (dryness resulting from the removal of water)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Lymphocyte count decreased
  6. Muscular weakness (muscle weakness)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. White blood cell count decreased
  10. Cerebral infarction (less blood supply to brain resulting tissue damage)

What are the existing conditions these people have? *

  1. Depression: 5 people, 31.25%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 31.25%
  3. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 18.75%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 18.75%
  5. Constipation: 3 people, 18.75%
  6. Bowel Movement Irregularity: 3 people, 18.75%
  7. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 12.50%
  8. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 12.50%
  9. Stress And Anxiety: 2 people, 12.50%
  10. Enlarged Prostate: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin sodium and Avapro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefazolin sodium and Avapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Avapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefazolin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and irbesartan (the active ingredients of Cefazolin sodium and Avapro, respectively), and Cefazolin sodium and Avapro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: